Inflammatory mechanisms in tendinopathy - towards translation (Q34549969)

3 August 2017

title

Inflammatory mechanisms in tendinopathy - towards translation (English)

1 reference

3 August 2017

0 references

Neal L Millar

1

1 reference

3 August 2017

George A C Murrell

series ordinal

2

1 reference

3 August 2017

Iain B McInnes

series ordinal

3

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 January 2017

1 reference

Nature Reviews Rheumatology

3 August 2017

published in

1 reference

3 August 2017

volume

13

1 reference

3 August 2017

issue

2

1 reference

3 August 2017

page(s)

110-122

1 reference

Chronic tendon pathology: molecular basis and therapeutic implications.

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Tendinopathy--from basic science to treatment

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Report on the Second international Enthesitis Workshop

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Time to abandon the "tendinitis" myth

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Overuse tendinosis, not tendinitis part 1: a new paradigm for a difficult clinical problem

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Risk factors for incident radiographic knee osteoarthritis in the elderly: the Framingham Study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Osteoarthritis as an inflammatory disease (osteoarthritis is not osteoarthrosis!).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Role of proinflammatory cytokines in the pathophysiology of osteoarthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Basic concepts of enthesis biology and immunology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

IL-23 induces spondyloarthropathy by acting on ROR-γt CD3 CD4-CD8- entheseal resident T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Proof of concept: enthesitis and new bone formation in spondyloarthritis are driven by mechanical strain and stromal cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

The basic science of tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Pathogenesis of tendinopathies: inflammation or degeneration?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Origin and physiological roles of inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Overuse tendon conditions: time to change a confusing terminology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Eccentric or Concentric Exercises for the Treatment of Tendinopathies?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Isometric exercise induces analgesia and reduces inhibition in patellar tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Treatment of Tendinopathy: What Works, What Does Not, and What is on the Horizon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

A treatment algorithm for managing Achilles tendinopathy: new treatment options

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Platelet-rich plasma treatment for ligament and tendon injuries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Treatment of lateral epicondylitis with platelet-rich plasma, glucocorticoid, or saline: a randomized, double-blind, placebo-controlled trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Mesenchymal stem cell therapy for equine tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Stem cells boom in vet clinics

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Function and biomechanics of tendons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Structure and metabolism of tendons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Tendon overload results in alterations in cell shape and increased markers of inflammation and matrix degradation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Effect of fatigue loading on structure and functional behaviour of fascicles from energy-storing tendons.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Histopathology of common tendinopathies. Update and implications for clinical management

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Light microscopic histology of achilles tendon ruptures. A comparison with unruptured tendons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Tenocytes from ruptured and tendinopathic achilles tendons produce greater quantities of type III collagen than tenocytes from normal achilles tendons. An in vitro model of human tendon healing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

The mechanobiological aetiopathogenesis of tendinopathy: is it the over-stimulation or the under-stimulation of tendon cells?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Abnormal tenocyte morphology is more prevalent than collagen disruption in asymptomatic athletes' patellar tendons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Histopathological findings in spontaneous tendon ruptures

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

3-D ultrastructure and collagen composition of healthy and overloaded human tendon: evidence of tenocyte and matrix buckling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Where is the pain coming from in tendinopathy? It may be biochemical, not only structural, in origin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Relationship between neovascularization and clinical severity in Achilles tendinopathy in 556 paired measurements

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Neovascularization in Achilles tendinopathy: have we been chasing a red herring?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Apoptosis in rotator cuff tendonopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Ex vivo static tensile loading inhibits MMP-1 expression in rat tail tendon cells through a cytoskeletally based mechanotransduction mechanism

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

The COL5A1 gene and Achilles tendon pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

The peripheral neuronal phenotype is important in the pathogenesis of painful human tendinopathy: a systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Cytokines and apoptosis in supraspinatus tendinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Tendinopathy and inflammation: some truths

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Is tendon pathology a continuum? A pathology model to explain the clinical presentation of load-induced tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

In situ microdialysis in tendon tissue: high levels of glutamate, but not prostaglandin E2 in chronic Achilles tendon pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Chronic tendon pain: no signs of chemical inflammation but high concentrations of the neurotransmitter glutamate. Implications for treatment?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Inflammation and the continuum model: time to acknowledge the molecular era of tendinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Inflammation in overuse tendon injuries

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Primed for inflammation: enthesis-resident T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Stromal cells in chronic inflammation and tertiary lymphoid organ formation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Rheumatoid synovial fibroblasts differentiate into distinct subsets in the presence of cytokines and cartilage.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Aging contributes to inflammation in upper extremity tendons and declines in forelimb agility in a rat model of upper extremity overuse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Increased mast cell numbers in a calcaneal tendon overuse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Macrophage polarization comes of age.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Macrophage activation and polarization: nomenclature and experimental guidelines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Macrophage sub-populations and the lipoxin A4 receptor implicate active inflammation during equine tendon repair

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Are the Symptoms of Calcific Tendinitis Due to Neoinnervation and/or Neovascularization?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Pathology of the torn rotator cuff tendon. Reduction in potential for repair as tear size increases

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Mast cells exert pro-inflammatory effects of relevance to the pathophyisology of tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Neutrophils and macrophages accumulate sequentially following Achilles tendon injury

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Are inflammatory cells increased in painful human tendinopathy? A systematic review

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Inflammation is present in early human tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Stereological quantification of immune-competent cells in baseline biopsy specimens from achilles tendons: results from patients with chronic tendinopathy followed for more than 4 years

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Achilles tendinosis is associated with sprouting of substance P positive nerve fibres

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

What are the validated animal models for tendinopathy?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Stretch and interleukin-1beta induce matrix metalloproteinases in rabbit tendon cells in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

IL-1 beta induces COX2, MMP-1, -3 and -13, ADAMTS-4, IL-1 beta and IL-6 in human tendon cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

TOL19-001 reduces inflammation and MMP expression in monolayer cultures of tendon cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Proteomic analysis of tendon extracellular matrix reveals disease stage-specific fragmentation and differential cleavage of COMP (cartilage oligomeric matrix protein).

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Interleukin 33 as a mechanically responsive cytokine secreted by living cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Disease-associated functions of IL-33: the new kid in the IL-1 family

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

MicroRNA29a regulates IL-33-mediated tissue remodelling in tendon disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Interleukin-6 and its receptor: from bench to bedside

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Increased expression of IL-6 family members in tendon pathology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Tendon healing in interleukin-4 and interleukin-6 knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Cyclic loading of tendon fascicles using a novel fatigue loading system increases interleukin-6 expression by tenocytes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Regulation of gene expression in human tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Substantial elevation of interleukin-6 concentration in peritendinous tissue, in contrast to muscle, following prolonged exercise in humans

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

In vivo biological response to extracorporeal shockwave therapy in human tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Muscle-derived interleukin-6: possible biological effects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Differences in tumor necrosis factor (TNF)alpha and TNF receptor-1-mediated intracellular signaling factors in normal, inflamed and scar-formed horse tendons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Tendon degeneration is not mediated by regulation of Toll-like receptors 2 and 4 in human tenocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

A pilot study on biomarkers for tendinopathy: lower levels of serum TNF-α and other cytokines in females but not males with Achilles tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

IL-13 receptors and signaling pathways: An evolving web

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Tendon properties in interleukin-4 and interleukin-6 knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Interleukins 4 and 13 modulate gene expression and promote proliferation of primary human tenocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Essential autocrine regulation by IL-21 in the generation of inflammatory T cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Interleukin-21: a double-edged sword with therapeutic potential

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

IL-21 receptor expression in human tendinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

The IL-23-IL-17 axis in inflammatory arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

IL-1-independent role of IL-17 in synovial inflammation and joint destruction during collagen-induced arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

IL-17A mediates inflammatory and tissue remodelling events in early human tendinopathy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Secukinumab, a human anti-interleukin-17A monoclonal antibody, in patients with psoriatic arthritis (FUTURE 2): a randomised, double-blind, placebo-controlled, phase 3 trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Ixekizumab, an interleukin-17A specific monoclonal antibody, for the treatment of biologic-naive patients with active psoriatic arthritis: results from the 24-week randomised, double-blind, placebo-controlled and active (adalimumab)-controlled perio

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Role of the immune system in chronic pain.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Cellular and Molecular Mechanisms of Pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Evidence for involvement of prostaglandin I2 as a major nociceptive mediator in acetic acid-induced writhing reaction: a study using IP-receptor disrupted mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Effect of prostaglandin E2 injection on the structural properties of the rat patellar tendon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Cyclical strain modulates metalloprotease and matrix gene expression in human tenocytes via activation of TGFβ

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Mechanisms of inflammatory pain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Microarray analysis of the tendinopathic rat supraspinatus tendon: glutamate signaling and its potential role in tendon degeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Differences in glutamate receptors and inflammatory cell numbers are associated with the resolution of pain in human rotator cuff tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Vascular endothelial cells synthesize nitric oxide from L-arginine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Modulation of tendon healing by nitric oxide

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Differential expression of cytokines and nitric oxide synthase isoforms in human rotator cuff bursae

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Temporal expression of nitric oxide synthase isoforms in healing Achilles tendon.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

The cell specific temporal expression of nitric oxide synthase isoforms during achilles tendon healing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Oxygen free radicals and tendon healing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Using nitric oxide to treat tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Nitric oxide enhances collagen synthesis in cultured human tendon cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Gene expression changes in SNAP-stimulated and iNOS-transfected tenocytes—expression of extracellular matrix genes and its implications for tendon-healing

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Resolution of inflammation: the beginning programs the end

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Proresolving lipid mediators and mechanisms in the resolution of acute inflammation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Pro-resolving lipid mediators are leads for resolution physiology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Inflamm-aging and arachadonic acid metabolite differences with stage of tendon disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Inflammation activation and resolution in human tendon disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

How cytokine networks fuel inflammation: Toward a cytokine-based disease taxonomy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Platelet-rich plasma modulates the secretion of inflammatory/angiogenic proteins by inflamed tenocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Stem cell applications in tendon disorders: a clinical perspective

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Macrophage depletion reduces cell proliferation and extracellular matrix accumulation but increases the ultimate tensile strength of injured Achilles tendons

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

AMPKα1 regulates macrophage skewing at the time of resolution of inflammation during skeletal muscle regeneration

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Adipose-derived mesenchymal stromal cells modulate tendon fibroblast responses to macrophage-induced inflammation in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Tenocyte responses to mechanical loading in vivo: a role for local insulin-like growth factor 1 signaling in early tendinosis in rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

p38 MAPK signaling in postnatal tendon growth and remodeling

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Protection against glucocorticoid-induced damage in human tenocytes by modulation of ERK, Akt, and forkhead signaling.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Hypoxia: a critical regulator of early human tendinopathy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Sirt-1 is required for the inhibition of apoptosis and inflammatory responses in human tenocytes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Curcumin modulates nuclear factor kappaB (NF-kappaB)-mediated inflammation in human tenocytes in vitro: role of the phosphatidylinositol 3-kinase/Akt pathway

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

State-of-the-art: rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Inhibition of p38: has the fat lady sung?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

The JAK inhibitor tofacitinib suppresses synovial JAK1-STAT signalling in rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Use of an IL1-receptor antagonist to prevent the progression of tendinopathy in a rat model.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Effects of interleukin-1 receptor antagonist on collagen and matrix metalloproteinases in stress-shielded achilles tendons of rats.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Effect of ultrasound-guided, peritendinous injections of adalimumab and anakinra in chronic Achilles tendinopathy: a pilot study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Interleukin-6: a growth factor stimulating collagen synthesis in human tendon

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Inflammatory resolution: new opportunities for drug discovery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

MicroRNAs: target recognition and regulatory functions

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

MicroRNA-210 overexpression induces angiogenesis and neurogenesis in the normal adult mouse brain

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

The effect of administration of double stranded MicroRNA-210 on acceleration of Achilles tendon healing in a rat model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Effectiveness of microRNA in Down-regulation of TGF-beta gene expression in digital flexor tendons of chickens: in vitro and in vivo study

31 March 2020

1 reference

https://api.crossref.org/works/10.1038/NRRHEUM.2016.213

Chitosan inhibits fibroblasts growth in Achilles tendon via TGF-β1/Smad3 pathway by miR-29b

31 March 2020

1 reference

12 December 2020

Histopathological changes preceding spontaneous rupture of a tendon. A controlled study of 891 patients

1 reference

12 December 2020

Anti-inflammatory management for tendon injuries - friends or foes?

1 reference

12 December 2020

The enthesis organ concept and its relevance to the spondyloarthropathies

1 reference

12 December 2020

Tendon injury and tendinopathy: healing and repair

1 reference

12 December 2020

Effect of pro-inflammatory and immunoregulatory cytokines on human tenocytes.

1 reference

12 December 2020

Deciphering the pathogenesis of tendinopathy: a three-stages process

1 reference

12 December 2020

1 reference

12 December 2020

Surgical treatment compared with eccentric training for patellar tendinopathy (Jumper's Knee). A randomized, controlled trial

1 reference

12 December 2020

The tensile properties of collagen fascicles harvested from regenerated and residual tissues in the patellar tendon after removal of the central third

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRRHEUM.2016.213

1 reference

Dimensions Publication ID

3 August 2017

1074213162

0 references

1 reference